📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib. (2024)

First Author: Rampotas A

Attributed to: Towards a CAR T-cell therapy approach for Calreticulin-mutated Myelofibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2023022345

PubMed Identifier: 37963262

Publication URI: http://europepmc.org/abstract/MED/37963262

Type: Journal Article/Review

Volume: 143

Parent Publication: Blood

Issue: 2

ISSN: 0006-4971